Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 3 | Song EstherSee Remarks | Open-market sale · 10b5-1 plan | SELL | $9,941 96 sh | Aug 19, 2026 |
| 3 | Song EstherSee Remarks | Open-market sale · 10b5-1 plan | SELL | $18K 177 sh | Aug 19, 2026 traded Aug 18, 2026 |
| 3 | Song EstherSee Remarks | Open-market sale · 10b5-1 plan | SELL | $17K 164 sh | Aug 19, 2026 traded Aug 18, 2026 |
| 2 | Foff Erin PennockChief Medical Officer | Grant or award | A | — 54.2K sh | Aug 19, 2026 traded Aug 17, 2026 |
| 2 | Foff Erin PennockChief Medical Officer | Grant or award | A | — 13.4K sh | Aug 19, 2026 traded Aug 17, 2026 |
| 2 | Fruhbeis Todd MichaelDirector | Option exercise | M | — 535 sh | Aug 19, 2026 traded Aug 18, 2026 |
| 1 | Dasdan AliChief Technology Officer | Tax withholding · 10b5-1 plan | F | $663K 19.3K sh | Aug 19, 2026 traded Aug 17, 2026 |
| 1 | Herrington Douglas JCEO Worldwide Amazon Stores | Option exercise · 10b5-1 plan | M | — 9,352 sh | Aug 19, 2026 traded Aug 15, 2026 |
| 1 | Starzak Alissa MichelleChief Legal Officer | Option exercise · 10b5-1 plan | M | $259K 3,333 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 1 | Kereere SuzanPresident, Global Markets | Open-market sale · 10b5-1 plan | SELL | $49K 800 sh | Aug 19, 2026 traded Aug 18, 2026 |
| 0 | Doyle MittieChief Medical Officer | Option exercise · 10b5-1 plan | M | — 1,000 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Ashish AroraDirector, Chief Executive Officer, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 1.75M sh | Aug 19, 2026 traded Aug 19, 2026 |
| 0 | Doyle MittieChief Medical Officer | Option exercise · 10b5-1 plan | M | $13K 1,000 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Lin XichenCHIEF SCIENTIFIC OFFICER | Derivative conversion · 10b5-1 plan | C | — 11.8K sh | Aug 19, 2026 traded Aug 18, 2026 |
| 0 | Sullivan Christopher RyanChief Financial Officer | Option exercise · 10b5-1 plan | M | $28K 2,876 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Riley JanelChief Accounting Officer | Option exercise · 10b5-1 plan | M | $113K 1,667 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Gupta VikramSee Remarks | Grant or award · 10b5-1 plan | A | — 15.3K sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Ashish AroraDirector, Chief Executive Officer, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 1.75M sh | Aug 19, 2026 traded Aug 19, 2026 |
| 0 | Starzak Alissa MichelleChief Legal Officer | Option exercise · 10b5-1 plan | M | — 3,333 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Gupta VikramSee Remarks | Grant or award · 10b5-1 plan | A | — 34.6K sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Lin XichenCHIEF SCIENTIFIC OFFICER | Derivative conversion · 10b5-1 plan | C | — 3,939 sh | Aug 19, 2026 traded Aug 18, 2026 |
| 0 | Hamady Robert RamseyChief Financial Officer | Option exercise · 10b5-1 plan | M | $0 0 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Lin XichenCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | $4,018 11.8K sh | Aug 19, 2026 traded Aug 18, 2026 |
| 0 | Song EstherSee Remarks | Grant or award · 10b5-1 plan | A | — 4,711 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Riley JanelChief Accounting Officer | Option exercise · 10b5-1 plan | M | — 1,667 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Hamady Robert RamseyChief Financial Officer | Option exercise · 10b5-1 plan | M | — 20.0K sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Sullivan Christopher RyanChief Financial Officer | Option exercise · 10b5-1 plan | M | — 31.0K sh | Aug 19, 2026 traded Aug 18, 2026 |
| 0 | Sullivan Christopher RyanChief Financial Officer | Option exercise · 10b5-1 plan | M | — 2,876 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Ellenbogen MichaelDirector | Option exercise · 10b5-1 plan | M | — 80.8K sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Song EstherSee Remarks | Tax withholding · 10b5-1 plan | F | $107K 972 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Sullivan Christopher RyanChief Financial Officer | Option exercise · 10b5-1 plan | M | — 37.9K sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Lin XichenCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | — 11.8K sh | Aug 19, 2026 traded Aug 18, 2026 |
| 0 | Ellenbogen MichaelDirector | Option exercise · 10b5-1 plan | M | $19K 80.8K sh | Aug 19, 2026 traded Aug 17, 2026 |
| 58 | Musser ForySenior VP, Development | Open-market sale | SELL | $6.27M 447.5K sh | Aug 18, 2026 traded Aug 14, 2026 |
| 55 | Musser ForySenior VP, Development | Open-market sale | SELL | $309K 22.0K sh | Aug 18, 2026 traded Aug 17, 2026 |
| 55 | Poletti Samuel JonasChief Strategy & M&A Officer | Open-market purchase | BUY | $118K 2,510 sh | Aug 18, 2026 traded Aug 17, 2026 |
| 53 | PM Alpha II DAC10% Owner | Open-market purchase | BUY | $1.33M 53.1K sh | Aug 18, 2026 traded Mar 2, 2026 |
| 49 | Allen RuthChief Human Resources Officer | Open-market sale | SELL | $624K 21.5K sh | Aug 18, 2026 traded Aug 17, 2026 |
| 49 | Chandrashekar LavanyaChief Financial Officer | Open-market sale | SELL | $510K 17.8K sh | Aug 18, 2026 traded Aug 17, 2026 |
| 46 | Delany JulianChief Technology Officer | Open-market sale | SELL | $50K 1,747 sh | Aug 18, 2026 traded Aug 17, 2026 |